Publications
75
Citations
394
Est. group size
~7
Recurring co-author estimate
Active years
16
Publishing since 2011
Meaghan M. Broman's research focuses on prostate diseases, especially benign prostatic hyperplasia (BPH) and prostate cancer, examining how immune cells and chronic inflammation contribute to abnormal tissue growth. Recent work also extends to biomarker discovery for cervical cancer screening. The research combines mouse models, single-cell RNA sequencing, and digital pathology/AI tools to study immune dysregulation in tissue.
Publication output was low and steady (2-4 per year) from 2017-2022, then increased sharply starting in 2023, suggesting a recent surge in research activity and output.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 5994: Mechanism of oncogenicity induced by overexpression of the PRL phosphatases
Cancer Research · 2026
- PD18-14 CHRONIC INFLAMMATION DRIVES EPITHELIAL REMODELING AND THERAPY-RESISTANT PROSTATE HYPERPLASIA
The Journal of Urology · 2026
- Immune dysregulation in the prostates of <scp>C57BL</scp> / <scp>6</scp> <sup> <i>Aire</i> −/− </sup> mice mirrors that seen in human benign prostatic hyperplasia
The Journal of Pathology · 2026
- Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia
Frontiers in Immunology · 2025
- Protein Biomarkers Enable Sensitive and Specific Cervical Intraepithelial Neoplasia (CIN) II/III+ Detection: One Step Closer to Universal Cervical Cancer Screening
Cancers · 2025
- Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasia
Frontiers in Immunology · 2025
- Validation of protein biomarkers for early detection of cervical cancer and squamous intraepithelial lesions.
Journal of Clinical Oncology · 2025
- Immune dysregulation in the prostates of C57BL/6 <sup>Aire-/-</sup> mice mirrors that seen in human benign prostatic hyperplasia
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- AnnotateAnyCell: Open-Source AI Framework for Efficient Annotation in Digital Pathology
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasia
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Supplementary Figure 2 from Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer
2023
- Supplementary Figure Legends from Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer
2023
- Supplementary Figure 1 from Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer
2023
- Data from Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer
2023
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Cancer Research×3
- The Prostate×2
- Frontiers in Immunology×2
- Cancer Letters×2
- Deborah W. Knapp
Medicine · Purdue University West Lafayette
- Marejka H. Shaevitz
Medicine · Purdue University West Lafayette
- Fanfei Meng
Medicine · Purdue University West Lafayette
- R. Timothy Bentley
Medicine · Purdue University West Lafayette
- Alexandre Matheus Baesso Cavalca
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile